No. Studies on ivermectin are mixed, and it seems like the ones that showed positive effects had falsified data[1]. Additionally, this trial does not demonstrate that Molnupiravir is ineffective after hospitalization.
The misinformation lies in the implication that we know with certainty that ivermectin is not an effective prophylactic/early stage treatment. We have a large body of mixed results.
They should just brand this drug as the "New Ivermectin", kill two birds with one stone and save countless lives. Comeon marketing people, I believe in you!
